Sauer Paul 4
4 · Vaxcyte, Inc. · Filed Mar 4, 2022
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Sauer Paul
SVP Process Dev, Manufacturing
Transactions
- Award
Common Stock
2022-03-02+10,000→ 37,125 total - Award
Stock Option (right to buy)
2022-03-02+60,000→ 60,000 totalExercise: $24.79Exp: 2032-03-01→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on September 2, 2022 and 12.5% of the shares every six months thereafter.
- [F2]1/48 of shares subject to the option vest on April 2, 2022, and 1/48 of the shares vest monthly thereafter.